Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Net Asset Momentum
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) recorded a net asset momentum of -322.6% as of December 2024, with net assets of $-44.54 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Amneal Pharmaceuticals, Inc. Class A Com (AMRX) tangible net worth to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Amneal Pharmaceuticals, Inc. Class A Common Stock Net Asset Momentum (2015–2024)
This chart tracks Amneal Pharmaceuticals, Inc. Class A Common Stock's year-over-year net asset growth across 10 annual reporting periods from 2015 to 2024. The most recent momentum reading is -322.6%, with net assets of $-44.54 Million USD as of December 2024. Read how much debt does Amneal Pharmaceuticals, Inc. Class A Com carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2024)
The table below shows the complete annual net asset history for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2024, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see AMRX market cap.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $-44.54 Million | $3.50 Billion | $3.55 Billion | ▼ -322.6% |
| 2023 | $20.01 Million | $3.47 Billion | $3.45 Billion | ▼ -90.4% |
| 2022 | $208.93 Million | $3.80 Billion | $3.59 Billion | ▼ -43.1% |
| 2021 | $366.97 Million | $3.94 Billion | $3.57 Billion | ▲ +6.4% |
| 2020 | $344.93 Million | $4.01 Billion | $3.66 Billion | ▼ -0.5% |
| 2019 | $346.79 Million | $3.67 Billion | $3.32 Billion | ▼ -61.3% |
| 2018 | $896.36 Million | $4.35 Billion | $3.46 Billion | ▲ +338.7% |
| 2017 | $-375.58 Million | $1.34 Billion | $1.72 Billion | ▼ -113.5% |
| 2016 | $-175.94 Million | $1.22 Billion | $1.39 Billion | ▲ +5.8% |
| 2015 | $-186.87 Million | $1.01 Billion | $1.20 Billion | — |